Skip to main content

Artivion, Inc.

AORT
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000784199

In the last 90 days, Artivion, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $1.04B in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $2.60M in total
6
13F holdersQ2 2026, −30 vs. previous quarter
206
13F valueReported value at the end of Q2 2026
$1.04B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding AORT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding AORT at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Artivion, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)5:28 PM ETSep 101 dayGreen Andrew MSVP, Regulatory and QualitySSale−11.5K$24.97−$286.7K−22.2%40.2K after
Sep 4, 2026 (view filing)2:15 PM ETSep 2-32 daysGreen Andrew MSVP, Regulatory and QualitySSale−8.00K$27.03−$216.3K−13.4%51.6K after2 lots
Aug 20, 2026 (view filing)2:11 PM ETAug 191 dayMackin James PPresident & CEOSSale−70.0K$28.96−$2.03M−7.4%877.3K after
Aug 17, 2026 (view filing)3:18 PM ETAug 143 daysGreen Andrew MSVP, Regulatory and QualitySSale−616$28.55−$17.6K−1.0%59.6K after
Aug 17, 2026 (view filing)3:17 PM ETAug 143 daysBerry Lance AEVP, COO, CFO & TreasurerSSale−715$28.55−$20.4K−0.3%210.1K after
Aug 12, 2026 (view filing)5:51 PM ETAug 12Same dayHolloway Jean FSVP, General CounselSSale−977$28.49−$27.8K−0.5%184.1K after
Jun 15, 2026 (view filing)Jun 114 daysGreen Andrew MSVP, Regulatory and QualitySSale−44.0K$20.70−$910.7K−42.2%60.3K after2 lots10b5-1
Mar 4, 2026 (view filing)Mar 31 dayHorton AmyVP, Chief Accounting OfficerSSale−901$37.78−$34.0K−0.6%139.1K after
Mar 4, 2026 (view filing)Mar 3-41 dayHolloway Jean FSVP, General CounselSSale−12.8K$37.93−$485.7K−6.5%185.1K after2 lots
Mar 4, 2026 (view filing)Mar 31 dayStanton Marshall S.SVP, Clinical & MD AffairSSale−2.15K$37.78−$81.2K−3.5%60.1K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Artivion, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 206 holders
Institutions holding AORT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.6,674,017$150.0M0.00%+199,163+3.1%Added
Nomura Asset Management International Inc.3,184,974$71.6M0.11%+728,828+29.7%Added
Morgan Stanley2,557,961$57.5M0.00%+288,667+12.7%Added
Juniper Investment Company, LLC2,019,885$45.4M12.02%+830,749+69.9%Added
Vanguard Capital Management LLC2,004,619$45.0M0.00%+52,611+2.7%Added
FMR LLC1,963,471$44.1M0.00%−619,956−24.0%Reduced
State Street Corp1,858,051$41.8M0.00%+175,778+10.4%Added
Ophir Asset Management Pty Ltd1,800,008$40.4M3.33%+849,158+89.3%Added
Perceptive Advisors LLC1,737,290$39.0M0.61%+100,000+6.1%Added
Conestoga Capital Advisors, LLC1,623,700$36.5M0.79%+448,290+38.1%Added